Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2016| July-August  | Volume 18 | Issue 4  
    Online since June 27, 2016

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery
Binod Kumar, Shawn E Lupold
July-August 2016, 18(4):559-567
DOI:10.4103/1008-682X.177839  PMID:27056344
  9 2,241 489
Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer
Jun Luo
July-August 2016, 18(4):580-585
DOI:10.4103/1008-682X.178490  PMID:27174161
  7 2,053 542
Clinical variability and molecular heterogeneity in prostate cancer
Jonathan Shoag, Christopher E Barbieri
July-August 2016, 18(4):543-548
DOI:10.4103/1008-682X.178852  PMID:27080479
  6 1,431 267
Potential role of punicalagin against oxidative stress induced testicular damage
Faiza Rao, Hui Tian, Wenqing Li, Helong Hung, Fei Sun
July-August 2016, 18(4):627-632
DOI:10.4103/1008-682X.168792  PMID:26763544
  6 1,594 295
Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer
Carly A Conran, Rong Na, Haitao Chen, Deke Jiang, Xiaoling Lin, S Lilly Zheng, Charles B Brendler, Jianfeng Xu
July-August 2016, 18(4):520-524
DOI:10.4103/1008-682X.179527  PMID:27080480
  5 1,321 300
Prostate cancer epigenetics and its clinical implications
Srinivasan Yegnasubramanian
July-August 2016, 18(4):549-558
DOI:10.4103/1008-682X.179859  PMID:27212125
  4 1,527 354
Clinical validity and utility of genetic risk scores in prostate cancer
Brian T Helfand, James Kearns, Carly Conran, Jianfeng Xu
July-August 2016, 18(4):509-514
DOI:10.4103/1008-682X.182981  PMID:27297129
  3 1,615 351
Clinically available RNA profiling tests of prostate tumors: utility and comparison
Rong Na, Yishuo Wu, Qiang Ding, Jianfeng Xu
July-August 2016, 18(4):575-579
DOI:10.4103/1008-682X.175096  PMID:26975490
  3 1,144 239
Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice
Zhi-Jun Zang, Hong-Feng Tang, Ying Tuo, Wei-Jie Xing, Su-Yun Ji, Yong Gao, Chun-Hua Deng
July-August 2016, 18(4):613-619
DOI:10.4103/1008-682X.166435  PMID:26608944
  3 1,421 286
Long noncoding RNAs in prostate cancer: overview and clinical implications
Bhavna Malik, Felix Y Feng
July-August 2016, 18(4):568-574
DOI:10.4103/1008-682X.177123  PMID:27072044
  2 2,485 520
Serum sex hormone and growth arrest-specific protein 6 levels in male patients with coronary heart disease
Rui Zhao, Yan Li, Wen Dai
July-August 2016, 18(4):644-649
DOI:10.4103/1008-682X.172825  PMID:26924277
  2 1,022 212
Air quality control in the ART laboratory is a major determinant of IVF success
Sandro C Esteves, Fabiola C Bento
July-August 2016, 18(4):596-599
DOI:10.4103/1008-682X.166433  PMID:26585700
  2 1,802 402
Personalized prostate cancer care: from screening to treatment
Carly A Conran, Charles B Brendler, Jianfeng Xu
July-August 2016, 18(4):505-508
DOI:10.4103/1008-682X.179529  PMID:27184548
  1 1,639 290
HOXB13 and other high penetrant genes for prostate cancer
Patrick G Pilie, Veda N Giri, Kathleen A Cooney
July-August 2016, 18(4):530-532
DOI:10.4103/1008-682X.175785  PMID:27034017
  1 1,092 229
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
Wennuan Liu
July-August 2016, 18(4):533-542
DOI:10.4103/1008-682X.177120  PMID:26975494
  1 1,270 299
A comparison of genetic risk score with family history for estimating prostate cancer risk
Brian T Helfand
July-August 2016, 18(4):515-519
DOI:10.4103/1008-682X.177122  PMID:27004541
  1 1,183 204
Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
Li Zhang, Jun Zhou, Song Fan, Chao-Zhao Liang
July-August 2016, 18(4):654-656
DOI:10.4103/1008-682X.157400  PMID:26208396
  1 1,706 257
Interaction between basigin and monocarboxylate transporter 2 in the mouse testes and spermatozoa
Cheng Chen, Mamiko Maekawa, Kenji Yamatoya, Masami Nozaki, Chizuru Ito, Toshihiko Iwanaga, Kiyotaka Toshimori
July-August 2016, 18(4):600-606
DOI:10.4103/1008-682X.157650  PMID:26208397
  1 1,342 194
Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells
Yuantong Tian, Lijing Zhao, Ye Wang, Haitao Zhang, Duo Xu, Xuejian Zhao, Yi Li, Jing Li
July-August 2016, 18(4):607-612
DOI:10.4103/1008-682X.169997  PMID:26698234
  1 1,789 302
The presence of human papillomavirus and Epstein-Barr virus in male Chinese lichen sclerosus patients: a single center study
Yumeng Zhang, Qiang Fu, Xiong Zhang
July-August 2016, 18(4):650-653
DOI:10.4103/1008-682X.160261  PMID:26289401
  1 1,350 203
Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
Guo-Peng Yu, Rong Na, Ding-Wei Ye, Jun Qi, Fang Liu, Hai-Tao Chen, Yi-Shuo Wu, Gui-Ming Zhang, Jie-Lin Sun, Yao Zhu, Li-Qun Huang, Shan-Cheng Ren, De-Ke Jiang, S Lilly Zheng, Hao-Wen Jiang, Ying-Hao Sun, Qiang Ding, Jianfeng Xu
July-August 2016, 18(4):633-638
DOI:10.4103/1008-682X.172823  PMID:26975483
  1 1,280 239
Translation of genomics and epigenomics in prostate cancer: progress and promising directions
Wennuan Liu, Jianfeng Xu
July-August 2016, 18(4):503-504
DOI:10.4103/1008-682X.182820  PMID:27270344
  - 1,157 275
Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases
Rong Na, Dingwei Ye, Jun Qi, Fang Liu, Xiaoling Lin, Brian T Helfand, Charles B Brendler, Carly Conran, Jian Gong, Yishuo Wu, Xu Gao, Yaqing Chen, S Lilly Zheng, Zengnan Mo, Qiang Ding, Yinghao Sun, Jianfeng Xu
July-August 2016, 18(4):525-529
DOI:10.4103/1008-682X.179857  PMID:27140652
  - 979 211
Genomic predictors for treatment of late stage prostate cancer
Daniel H Shevrin
July-August 2016, 18(4):586-591
DOI:10.4103/1008-682X.177121  PMID:27030083
  - 1,466 333
Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
Yuan Gao, Chen-Yi Jiang, Shi-Kui Mao, Di Cui, Kui-Yuan Hao, Wei Zhao, Qi Jiang, Yuan Ruan, Shu-Jie Xia, Bang-Min Han
July-August 2016, 18(4):639-643
DOI:10.4103/1008-682X.169984  PMID:26732103
  - 1,147 205
Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro
Mark J McCabe, Caroline FH Foo, Marcel E Dinger, Peter M Smooker, Peter G Stanton
July-August 2016, 18(4):620-626
DOI:10.4103/1008-682X.163189  PMID:26585695
  - 1,783 263
The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer
Jeanny B Aragon-Ching
July-August 2016, 18(4):592-593
DOI:10.4103/1008-682X.172821  PMID:26908063
  - 1,009 182
Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
Laura E Pascal, Zhou Wang
July-August 2016, 18(4):594-595
DOI:10.4103/1008-682X.168793  PMID:26763545
  - 1,265 257